Retatrutide pricing is speculative since it is not yet approved, but analysts estimate it will launch at $1,100-1,400 per month, roughly competitive with semaglutide
Some of the health issues linked to the use of GLP-1 drugs and dual GIP/GLP-1 medications include pancreatitis, gallbladder problems, kidney disease, heart palpitations, and gastrointestinal health problems
Furthermore, some bioactive ingredients have diuretic qualities that help with sodium excretion and fluid retention, both of which help control hypertension and fluid overload associated with CKD [62]
Many people refer to Vitamin B and think it is just one particular vitamin, but its composed of eight essential nutrients
Hans Herrings was sponsored by Novo Nordisk to organise, collect data for and advise on, the PIONEER REAL Netherlands study
The medication's effects on gastric emptying, weight loss velocity, and metabolic changes all have potential implications for gallstone formation, making this an important clinical consideration for prescribers and patients alike